Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 3Neoplasms 2Esophageal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Nasopharyngeal Carcinoma 1Melanoma 1Locally Advanced Rectal Adenocarcinoma 1Locally Advanced Cervical Carcinoma 1Liver Neoplasms 1Liver Diseases 1Gastric Cancer With Liver Metastases 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Breast Neoplasms, Male 1Adenocarcinoma 1

Interventions

Oxaliplatin 8Fluorouracil 8pembrolizumab 7Paclitaxel 6Trastuzumab 5Leucovorin 5Capecitabine 5Specimen Handling 4Radiation 4Cisplatin 4Carboplatin 4tislelizumab 3patritumab deruxtecan 3Taxes 3Radiotherapy 3Nivolumab 3ulixertinib 2trastuzumab deruxtecan 2trastuzumab biosimilar HLX02 2durvalumab 2Surgical Procedures, Operative 2Ramucirumab 2Pemetrexed 2PF-05280014 2Ontruzant 2Ogivri 2Magnetic Resonance Spectroscopy 2Irinotecan 2Immunotherapy 2Exercise 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Immunotherapy × 30 days × Clear all
NCT07162506 2026-05-29

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
120 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT07000253 2026-05-07

OMEC-5

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2/3 Recruiting
290 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡